AirSculpt Technologies, Inc.

AIRS ·Healthcare, Medical Care Facilities, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Revenue $151.8M $180.4M $195.9M $168.8M $133.3M $62.8M $41.2M
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development
SG&A Expense $82.2M $98.9M $102.4M $101.4M $65.7M $23.6M $20.1M
Operating Income $-11.6M $-1.6M $9.7M $-4.5M $15.8M $10.0M $663.0K
Operating Margin -7.6% -0.9% 5.0% -2.7% 11.8% 16.0% 1.6%
Interest Expense $6.5M $6.8M $4.9M $2.5M $2.9M
Pretax Income $-17.6M $-7.8M $3.2M $-11.3M $10.9M $7.6M $-2.2M
Income Tax Expense $-6.0M $188.0K $7.5M $3.4M $329.0K $0 $0
Net Income $-11.7M $-8.0M $-4.2M $-14.7M $10.6M $7.6M $-2.2M
Net Margin -7.7% -4.4% -2.2% -8.7% 7.9% 12.1% -5.4%
EPS (Basic) $-0.19 $-0.14 $-0.08 $-0.26 $-0.01
EPS (Diluted) $-0.19 $-0.14 $-0.08 $-0.26 $-0.01
Shares Outstanding (Basic) 60.5M 57.7M 56.8M 55.7M 55.6M 0
Shares Outstanding (Diluted) 60.5M 57.7M 56.8M 55.7M 55.6M 0
Dividends Per Share $0.41